Rhythm Pharmaceuticals, Inc. (RYTM) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results - Rhythm Pharmaceutical
Rhythm Pharmaceuticals: Umsatz im ersten Vierteljährlich 2026 übertrifft Erwartungen dank erfolgreicher Markteinführung
Analysts Estimate Rhythm Pharmaceuticals, Inc. (RYTM) to Report a Decline in Earnings: What to Look Out for